Create a free Cannabis Equipment News account to continue

SOMAƍ Group Expands Cookies Partnership to Include Europe and the UK

It enables SOMAƍ to exclusively cultivate, manufacture, and distribute Cookies branded products.

Screenshot 2024 05 22 At 2 40 30 Pm
SOMAƍ Group

SOMAƍ Group and its subsidiary, RPK Biopharma expanded their existing partnership with Cookies Creative Consulting & Promotions, Inc., a California corporation to include additional territories for the dried flower portfolio and manufacture different extract products.

The amendment enables SOMAƍ to exclusively cultivate, manufacture, and distribute Cookies branded products through its distribution partners in UK, Germany, Portugal, Poland, Malta, and the Czech Republic. Cookies is globally recognized as the most sought-after and top-selling cannabis brands with a growing international footprint. The diverse portfolio, including over 70 proprietary cannabis cultivars and more than 2,000 products that Cookies developed over the years, has solidified its reputation for delivering premium quality to consumers worldwide.

The Cookies brand is a name synonymous with the US cannabis market, and its long-awaited launch in Europe is set to create a new standard of quality for flower and extracted products.Under the terms of the agreement, SOMAƍ's subsidiary RPK Biopharma will cultivate Cookies licensed genetics at their large scale state-of-the-art indoor cultivation facilities located in Portugal, to be later distributed through its partners in Germany, the UK, Portugal, Poland, Malta, and the Czech Republic.

SOMAƍ will also leverage RPK Biopharmaā€™s vast EU-GMP processing capabilities to serve as a hub for importing Cookies branded products from around the world. Furthermore, SOMAƍ's medical subsidiary SOMAƍ Pharmaceuticals will utilize its cutting-edge EU-GMP manufacturing capabilities to transform Cookies Flower into a range of next-generation products tailored to meet the evolving demands of patients, ranging from oral drops and soft gel capsules to vape oils and gummies. Combined with market-leading and innovative Cookies' genetics, RPK's premium cultivation proficiency, and SOMAƍ's groundbreaking manufacturing expertise, companies are poised to deliver premium cannabinoid therapeutics that excel at the standards of excellence within the largest and fastest-growing international markets.

More in Distribution